Prospective clinical study of early diagnosis and treatment for intravasclular large B-cell lymphoma (IVL)
Phase 2
- Conditions
- Intravascular large B -cell lymphoma: IV
- Registration Number
- JPRN-UMIN000001309
- Lead Sponsor
- Department of Hematology and Immunology, Kanazawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1, collagen vascular disease 2, Severe infectious disease 3, Pre-treatment history for lymphoma 4, HIV+, HTLV1+ or HBV-Ag+ 5, Physician's decision of inappropriateness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival
- Secondary Outcome Measures
Name Time Method CR rate, Adverse events, Correspondence rate between early clinical diagnosis and pathological diagnosis, Diagnostic rate of bone marrow and/or random skin biopsy, Time to treatment failure